Annual Gross Profit
$7.64 B
+$672.00 M+9.64%
31 December 2023
Summary:
Teva Pharmaceutical Industries Limited annual gross profit is currently $7.64 billion, with the most recent change of +$672.00 million (+9.64%) on 31 December 2023. During the last 3 years, it has fallen by -$81.00 million (-1.05%). TEVA annual gross profit is now -34.39% below its all-time high of $11.65 billion, reached on 31 December 2016.TEVA Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Gross Profit
$2.15 B
+$124.00 M+6.13%
30 September 2024
Summary:
Teva Pharmaceutical Industries Limited quarterly gross profit is currently $2.15 billion, with the most recent change of +$124.00 million (+6.13%) on 30 September 2024. Over the past year, it has increased by +$297.00 million (+16.05%). TEVA quarterly gross profit is now -32.54% below its all-time high of $3.18 billion, reached on 31 December 2016.TEVA Quarterly Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Gross Profit
$8.36 B
+$297.00 M+3.68%
30 September 2024
Summary:
Teva Pharmaceutical Industries Limited TTM gross profit is currently $8.36 billion, with the most recent change of +$297.00 million (+3.68%) on 30 September 2024. Over the past year, it has increased by +$1.36 billion (+19.42%). TEVA TTM gross profit is now -28.57% below its all-time high of $11.70 billion, reached on 31 March 2017.TEVA TTM Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TEVA Gross Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +9.6% | +16.1% | +19.4% |
| 3 y3 years | -1.1% | +19.7% | +10.1% |
| 5 y5 years | -7.8% | +17.4% | +10.7% |
TEVA Gross Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -1.1% | +9.6% | -11.1% | +35.8% | at high | +22.6% |
| 5 y | 5 years | -7.8% | +9.6% | -11.1% | +35.8% | at high | +22.6% |
| alltime | all time | -34.4% | >+9999.0% | -32.5% | +2321.7% | -28.6% | +8419.9% |
Teva Pharmaceutical Industries Limited Gross Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $2.15 B(+6.1%) | $8.36 B(+3.7%) |
| June 2024 | - | $2.02 B(+14.3%) | $8.06 B(+2.9%) |
| Mar 2024 | - | $1.77 B(-26.7%) | $7.83 B(+2.5%) |
| Dec 2023 | $7.64 B(+9.6%) | $2.42 B(+30.5%) | $7.64 B(+9.2%) |
| Sept 2023 | - | $1.85 B(+3.1%) | $7.00 B(+2.7%) |
| June 2023 | - | $1.80 B(+13.5%) | $6.82 B(+0.0%) |
| Mar 2023 | - | $1.58 B(-10.6%) | $6.82 B(-2.3%) |
| Dec 2022 | $6.97 B(-8.2%) | $1.77 B(+6.1%) | $6.97 B(-3.9%) |
| Sept 2022 | - | $1.67 B(-7.0%) | $7.25 B(-1.7%) |
| June 2022 | - | $1.79 B(+3.1%) | $7.38 B(-1.1%) |
| Mar 2022 | - | $1.74 B(-15.1%) | $7.46 B(-1.8%) |
| Dec 2021 | $7.59 B(-1.7%) | $2.05 B(+14.3%) | $7.59 B(+0.0%) |
| Sept 2021 | - | $1.79 B(-4.2%) | $7.59 B(-0.8%) |
| June 2021 | - | $1.87 B(-0.3%) | $7.65 B(+1.5%) |
| Mar 2021 | - | $1.88 B(-8.3%) | $7.54 B(-2.4%) |
| Dec 2020 | $7.73 B(+2.5%) | $2.05 B(+10.6%) | $7.73 B(+1.2%) |
| Sept 2020 | - | $1.85 B(+5.0%) | $7.64 B(+0.3%) |
| June 2020 | - | $1.76 B(-14.5%) | $7.61 B(-1.7%) |
| Mar 2020 | - | $2.06 B(+5.4%) | $7.74 B(+2.7%) |
| Dec 2019 | $7.54 B(-9.1%) | $1.96 B(+7.0%) | $7.54 B(-0.2%) |
| Sept 2019 | - | $1.83 B(-3.3%) | $7.55 B(-1.9%) |
| June 2019 | - | $1.89 B(+2.0%) | $7.70 B(-1.8%) |
| Mar 2019 | - | $1.86 B(-5.8%) | $7.84 B(-5.5%) |
| Dec 2018 | $8.30 B(-21.8%) | $1.97 B(-0.3%) | $8.30 B(-3.5%) |
| Sept 2018 | - | $1.98 B(-2.8%) | $8.60 B(-7.3%) |
| June 2018 | - | $2.03 B(-12.2%) | $9.27 B(-8.1%) |
| Mar 2018 | - | $2.31 B(+1.9%) | $10.09 B(-4.9%) |
| Dec 2017 | $10.62 B(-8.9%) | $2.27 B(-14.3%) | $10.62 B(-7.9%) |
| Sept 2017 | - | $2.65 B(-7.2%) | $11.53 B(-1.3%) |
| June 2017 | - | $2.85 B(+0.6%) | $11.68 B(-0.2%) |
| Mar 2017 | - | $2.84 B(-10.8%) | $11.70 B(+0.4%) |
| Dec 2016 | $11.65 B(+2.6%) | $3.18 B(+13.7%) | $11.65 B(+3.0%) |
| Sept 2016 | - | $2.80 B(-2.6%) | $11.32 B(+0.3%) |
| June 2016 | - | $2.88 B(+3.1%) | $11.29 B(-0.2%) |
| Mar 2016 | - | $2.79 B(-2.0%) | $11.31 B(-0.4%) |
| Dec 2015 | $11.36 B(+2.7%) | $2.85 B(+2.7%) | $11.36 B(-0.4%) |
| Sept 2015 | - | $2.77 B(-4.5%) | $11.40 B(-0.3%) |
| June 2015 | - | $2.90 B(+2.3%) | $11.44 B(+2.2%) |
| Mar 2015 | - | $2.84 B(-1.8%) | $11.20 B(+1.3%) |
| Dec 2014 | $11.06 B(+3.3%) | $2.89 B(+2.8%) | $11.06 B(-0.0%) |
| Sept 2014 | - | $2.81 B(+5.6%) | $11.06 B(+1.6%) |
| June 2014 | - | $2.66 B(-1.3%) | $10.88 B(+0.6%) |
| Mar 2014 | - | $2.70 B(-6.8%) | $10.81 B(+1.0%) |
| Dec 2013 | $10.71 B(+0.5%) | $2.89 B(+10.0%) | $10.71 B(+1.0%) |
| Sept 2013 | - | $2.63 B(+1.4%) | $10.60 B(+0.3%) |
| June 2013 | - | $2.59 B(+0.1%) | $10.57 B(-0.6%) |
| Mar 2013 | - | $2.59 B(-7.0%) | $10.63 B(-0.2%) |
| Dec 2012 | $10.65 B(+11.9%) | $2.79 B(+7.1%) | $10.65 B(-0.9%) |
| Sept 2012 | - | $2.60 B(-2.1%) | $10.75 B(+3.4%) |
| June 2012 | - | $2.66 B(+1.8%) | $10.39 B(+4.6%) |
| Mar 2012 | - | $2.61 B(-9.4%) | $9.94 B(+4.4%) |
| Dec 2011 | $9.52 B(+5.0%) | $2.88 B(+28.3%) | $9.52 B(+4.6%) |
| Sept 2011 | - | $2.25 B(+2.1%) | $9.10 B(-2.4%) |
| June 2011 | - | $2.20 B(+0.5%) | $9.32 B(+0.9%) |
| Mar 2011 | - | $2.19 B(-11.2%) | $9.24 B(+1.9%) |
| Dec 2010 | $9.06 B(+23.0%) | $2.46 B(-0.1%) | $9.06 B(+4.2%) |
| Sept 2010 | - | $2.47 B(+16.3%) | $8.70 B(+6.6%) |
| June 2010 | - | $2.12 B(+5.4%) | $8.16 B(+4.5%) |
| Mar 2010 | - | $2.01 B(-4.1%) | $7.81 B(+6.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2009 | $7.37 B(+23.4%) | $2.10 B(+8.9%) | $7.37 B(+7.3%) |
| Sept 2009 | - | $1.93 B(+9.0%) | $6.87 B(+6.8%) |
| June 2009 | - | $1.77 B(+12.6%) | $6.43 B(+4.3%) |
| Mar 2009 | - | $1.57 B(-1.8%) | $6.17 B(+3.3%) |
| Dec 2008 | $5.97 B(+22.4%) | $1.60 B(+7.2%) | $5.97 B(+4.4%) |
| Sept 2008 | - | $1.49 B(-0.9%) | $5.72 B(+4.4%) |
| June 2008 | - | $1.50 B(+9.7%) | $5.47 B(+5.0%) |
| Mar 2008 | - | $1.37 B(+1.9%) | $5.21 B(+6.9%) |
| Dec 2007 | $4.88 B(+14.5%) | $1.35 B(+7.8%) | $4.88 B(+5.3%) |
| Sept 2007 | - | $1.25 B(+0.6%) | $4.63 B(-0.3%) |
| June 2007 | - | $1.24 B(+19.9%) | $4.64 B(+1.6%) |
| Mar 2007 | - | $1.04 B(-5.9%) | $4.57 B(+7.3%) |
| Dec 2006 | $4.26 B(+71.7%) | $1.10 B(-12.6%) | $4.26 B(+11.1%) |
| Sept 2006 | - | $1.26 B(+7.7%) | $3.83 B(+20.2%) |
| June 2006 | - | $1.17 B(+61.8%) | $3.19 B(+22.7%) |
| Mar 2006 | - | $724.00 M(+7.1%) | $2.60 B(+4.9%) |
| Dec 2005 | $2.48 B(+10.8%) | $675.90 M(+9.3%) | $2.48 B(+2.5%) |
| Sept 2005 | - | $618.60 M(+6.3%) | $2.42 B(+1.2%) |
| June 2005 | - | $581.80 M(-3.6%) | $2.39 B(+1.2%) |
| Mar 2005 | - | $603.70 M(-1.9%) | $2.36 B(+5.5%) |
| Dec 2004 | $2.24 B(+47.4%) | $615.70 M(+4.4%) | $2.24 B(+8.9%) |
| Sept 2004 | - | $589.60 M(+6.6%) | $2.06 B(+11.5%) |
| June 2004 | - | $553.30 M(+15.2%) | $1.84 B(+11.7%) |
| Mar 2004 | - | $480.40 M(+10.9%) | $1.65 B(+8.7%) |
| Dec 2003 | $1.52 B(+38.7%) | $433.00 M(+14.8%) | $1.52 B(+6.6%) |
| Sept 2003 | - | $377.20 M(+4.7%) | $1.43 B(+8.1%) |
| June 2003 | - | $360.30 M(+3.4%) | $1.32 B(+9.4%) |
| Mar 2003 | - | $348.40 M(+2.7%) | $1.21 B(+10.0%) |
| Dec 2002 | $1.10 B(+29.3%) | $339.20 M(+25.4%) | $1.10 B(+10.0%) |
| Sept 2002 | - | $270.60 M(+9.5%) | $996.09 M(+7.0%) |
| June 2002 | - | $247.10 M(+3.6%) | $931.19 M(+4.8%) |
| Mar 2002 | - | $238.50 M(-0.6%) | $888.84 M(+4.9%) |
| Dec 2001 | $847.29 M(+7.7%) | $239.89 M(+16.6%) | $847.30 M(-6.7%) |
| Sept 2001 | - | $205.70 M(+0.5%) | $908.08 M(+2.9%) |
| June 2001 | - | $204.75 M(+4.0%) | $882.71 M(+1.4%) |
| Mar 2001 | - | $196.96 M(-34.5%) | $870.86 M(+7.3%) |
| Dec 2000 | $786.86 M(+34.9%) | $300.67 M(+66.7%) | $811.48 M(+10.9%) |
| Sept 2000 | - | $180.33 M(-6.5%) | $731.91 M(+7.6%) |
| June 2000 | - | $192.90 M(+40.2%) | $680.02 M(+11.9%) |
| Mar 2000 | - | $137.58 M(-37.8%) | $607.97 M(+4.2%) |
| Dec 1999 | $583.20 M(+21.5%) | $221.10 M(+72.1%) | $583.20 M(+8.5%) |
| Sept 1999 | - | $128.44 M(+6.3%) | $537.73 M(+2.1%) |
| June 1999 | - | $120.84 M(+7.1%) | $526.59 M(+6.5%) |
| Mar 1999 | - | $112.82 M(-35.8%) | $494.45 M(+3.1%) |
| Dec 1998 | $479.83 M(-1.7%) | $175.63 M(+49.7%) | $479.73 M(+57.8%) |
| Sept 1998 | - | $117.30 M(+32.2%) | $304.10 M(+62.8%) |
| June 1998 | - | $88.70 M(-9.6%) | $186.80 M(+90.4%) |
| Mar 1998 | - | $98.10 M | $98.10 M |
| Dec 1997 | $488.00 M(+21.0%) | - | - |
| Dec 1996 | $403.40 M(+22.3%) | - | - |
| Dec 1995 | $329.80 M(+5.7%) | - | - |
| Dec 1994 | $312.10 M(+33.7%) | - | - |
| Dec 1993 | $233.50 M(+35.4%) | - | - |
| Dec 1992 | $172.50 M(+29.7%) | - | - |
| Dec 1991 | $133.00 M(-3.4%) | - | - |
| Dec 1990 | $137.70 M(+37.2%) | - | - |
| Dec 1989 | $100.40 M(+23.0%) | - | - |
| Dec 1988 | $81.60 M(+49.2%) | - | - |
| Mar 1987 | $54.70 M(+68.8%) | - | - |
| Mar 1986 | $32.40 M | - | - |
FAQ
- What is Teva Pharmaceutical Industries Limited annual gross profit?
- What is the all time high annual gross profit for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited annual gross profit year-on-year change?
- What is Teva Pharmaceutical Industries Limited quarterly gross profit?
- What is the all time high quarterly gross profit for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited quarterly gross profit year-on-year change?
- What is Teva Pharmaceutical Industries Limited TTM gross profit?
- What is the all time high TTM gross profit for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited TTM gross profit year-on-year change?
What is Teva Pharmaceutical Industries Limited annual gross profit?
The current annual gross profit of TEVA is $7.64 B
What is the all time high annual gross profit for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high annual gross profit is $11.65 B
What is Teva Pharmaceutical Industries Limited annual gross profit year-on-year change?
Over the past year, TEVA annual gross profit has changed by +$672.00 M (+9.64%)
What is Teva Pharmaceutical Industries Limited quarterly gross profit?
The current quarterly gross profit of TEVA is $2.15 B
What is the all time high quarterly gross profit for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high quarterly gross profit is $3.18 B
What is Teva Pharmaceutical Industries Limited quarterly gross profit year-on-year change?
Over the past year, TEVA quarterly gross profit has changed by +$297.00 M (+16.05%)
What is Teva Pharmaceutical Industries Limited TTM gross profit?
The current TTM gross profit of TEVA is $8.36 B
What is the all time high TTM gross profit for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high TTM gross profit is $11.70 B
What is Teva Pharmaceutical Industries Limited TTM gross profit year-on-year change?
Over the past year, TEVA TTM gross profit has changed by +$1.36 B (+19.42%)